Navamedic
Pharmaceutical products and therapies for hospitals, pharmacies and healthcare partners across Nordic and Benelux markets
Highlights
- New on EvolcAdded 2026-10-27
About Navamedic
Navamedic supplies prescription medicines, consumer health products and hospital-critical therapies. Its portfolio includes treatments related to obesity, Parkinson’s disease, opioid dependence, antibiotics and other health conditions.
The company supplies hospitals and pharmacies and partners with international pharmaceutical companies on market access and commercialisation. Its products are sold in 16 countries.
Founded in 2002, Navamedic is headquartered in Oslo and has been listed on the Oslo Stock Exchange since 2006.
Product: Portfolio of prescription medicines, consumer health products and hospital-critical therapies supplied to healthcare providers and pharmacies.
Jobs at Navamedic
More biotech & pharma companies
Nextera
Discovers TCR-like antibody drug candidates against disease-specific pHLA targets for cancer and autoimmune diseaseNew on EvolcNocteva
Organoid models and drug discovery services for rare disease researchers and biotech companiesYoung companyNew on EvolcNorsk Medisinsk Syklotronsenter
Makes short-lived PET radiopharmaceuticals for diagnostic imaging, serving clinics and pharma partners from OsloNew on EvolcNuclithera
Targeted radiopharmaceuticals for patients with metastatic and difficult-to-treat cancersYoung companyNew on EvolcNykode Therapeutics
Develops immunotherapies for patients with cancer and autoimmune diseases using a modular biotech platformOncosyne
Tumoroid-based drug screening and predictive diagnostics for pharmaceutical companies and cancer care providersNew on Evolc
.png){kind=small}
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Google Tag Manager
- WordPress
- jQuery